138 related articles for article (PubMed ID: 23045977)
1. Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection.
Hinkel R; Trenkwalder T; Kupatt C
Ann N Y Acad Sci; 2012 Oct; 1269():102-9. PubMed ID: 23045977
[TBL] [Abstract][Full Text] [Related]
2. Thymosin β4-mediated protective effects in the heart.
Hinkel R; Klett K; Bähr A; Kupatt C
Expert Opin Biol Ther; 2018 Jul; 18(sup1):121-129. PubMed ID: 30063857
[TBL] [Abstract][Full Text] [Related]
3. C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair.
Hinkel R; Ball HL; DiMaio JM; Shrivastava S; Thatcher JE; Singh AN; Sun X; Faskerti G; Olson EN; Kupatt C; Bock-Marquette I
J Mol Cell Cardiol; 2015 Oct; 87():113-25. PubMed ID: 26255251
[TBL] [Abstract][Full Text] [Related]
4. Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia.
Hinkel R; Bock-Marquette I; Hatzopoulos AK; Kupatt C
Ann N Y Acad Sci; 2010 Apr; 1194():105-11. PubMed ID: 20536456
[TBL] [Abstract][Full Text] [Related]
5. Embryonic endothelial progenitor cell-mediated cardioprotection requires Thymosin beta4.
Kupatt C; Bock-Marquette I; Boekstegers P
Trends Cardiovasc Med; 2008 Aug; 18(6):205-10. PubMed ID: 19185810
[TBL] [Abstract][Full Text] [Related]
6. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.
Bock-Marquette I; Saxena A; White MD; Dimaio JM; Srivastava D
Nature; 2004 Nov; 432(7016):466-72. PubMed ID: 15565145
[TBL] [Abstract][Full Text] [Related]
7. Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart.
Smart N; Bollini S; Dubé KN; Vieira JM; Zhou B; Riegler J; Price AN; Lythgoe MF; Davidson S; Yellon D; Pu WT; Riley PR
Ann N Y Acad Sci; 2012 Oct; 1269():92-101. PubMed ID: 23045976
[TBL] [Abstract][Full Text] [Related]
8. Thymosin beta4 is cardioprotective after myocardial infarction.
Srivastava D; Saxena A; Michael Dimaio J; Bock-Marquette I
Ann N Y Acad Sci; 2007 Sep; 1112():161-70. PubMed ID: 17600280
[TBL] [Abstract][Full Text] [Related]
9. Cardiac repair with thymosin β4 and cardiac reprogramming factors.
Srivastava D; Ieda M; Fu J; Qian L
Ann N Y Acad Sci; 2012 Oct; 1270():66-72. PubMed ID: 23050819
[TBL] [Abstract][Full Text] [Related]
10. Thymosin beta4 and cardiac repair.
Shrivastava S; Srivastava D; Olson EN; DiMaio JM; Bock-Marquette I
Ann N Y Acad Sci; 2010 Apr; 1194():87-96. PubMed ID: 20536454
[TBL] [Abstract][Full Text] [Related]
11. Regulation of PTEN/Akt pathway enhances cardiomyogenesis and attenuates adverse left ventricular remodeling following thymosin β4 Overexpressing embryonic stem cell transplantation in the infarcted heart.
Yan B; Singla RD; Abdelli LS; Singal PK; Singla DK
PLoS One; 2013; 8(9):e75580. PubMed ID: 24086577
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of thymosin β4 in myocardial infarct and heart failure.
Stark C; Taimen P; Tarkia M; Pärkkä J; Saraste A; Alastalo TP; Savunen T; Koskenvuo J
Ann N Y Acad Sci; 2012 Oct; 1269():117-24. PubMed ID: 23045979
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
Cavasin MA
Am J Cardiovasc Drugs; 2006; 6(5):305-11. PubMed ID: 17083265
[TBL] [Abstract][Full Text] [Related]
14. Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection.
Hinkel R; El-Aouni C; Olson T; Horstkotte J; Mayer S; Müller S; Willhauck M; Spitzweg C; Gildehaus FJ; Münzing W; Hannappel E; Bock-Marquette I; DiMaio JM; Hatzopoulos AK; Boekstegers P; Kupatt C
Circulation; 2008 Apr; 117(17):2232-40. PubMed ID: 18427126
[TBL] [Abstract][Full Text] [Related]
15. Development of thymosin beta4 for treatment of patients with ischemic heart disease.
Crockford D
Ann N Y Acad Sci; 2007 Sep; 1112():385-95. PubMed ID: 17947592
[TBL] [Abstract][Full Text] [Related]
16. The actin binding site on thymosin beta4 promotes angiogenesis.
Philp D; Huff T; Gho YS; Hannappel E; Kleinman HK
FASEB J; 2003 Nov; 17(14):2103-5. PubMed ID: 14500546
[TBL] [Abstract][Full Text] [Related]
17. Thymosin β4 and cardiac regeneration: are we missing a beat?
Gajzer DC; Balbin J; Chaudhry HW
Stem Cell Rev Rep; 2013 Jun; 9(3):303-12. PubMed ID: 22628110
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection by Thymosin Beta 4.
Pipes GT; Yang J
Vitam Horm; 2016; 102():209-26. PubMed ID: 27450736
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.
Lähteenvuo JE; Lähteenvuo MT; Kivelä A; Rosenlew C; Falkevall A; Klar J; Heikura T; Rissanen TT; Vähäkangas E; Korpisalo P; Enholm B; Carmeliet P; Alitalo K; Eriksson U; Ylä-Herttuala S
Circulation; 2009 Feb; 119(6):845-56. PubMed ID: 19188502
[TBL] [Abstract][Full Text] [Related]
20. Thymosin beta4 facilitates epicardial neovascularization of the injured adult heart.
Smart N; Risebro CA; Clark JE; Ehler E; Miquerol L; Rossdeutsch A; Marber MS; Riley PR
Ann N Y Acad Sci; 2010 Apr; 1194():97-104. PubMed ID: 20536455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
